Prednisone and Diffuse large b-cell lymphoma stage iii - a phase IV clinical study of FDA data

Summary:

Diffuse large b-cell lymphoma stage iii is reported as a side effect among people who take Prednisone (prednisone), especially for people who are female, 10-19 old, have been taking the drug for 2 - 5 years also take Methotrexate, and have Crohn's disease.

The phase IV clinical study analyzes which people have Diffuse large b-cell lymphoma stage iii when taking Prednisone. It is created by eHealthMe based on reports of 628,814 people who have side effects when taking Prednisone from the FDA, and is updated regularly.

What is Prednisone?

Prednisone has active ingredients of prednisone. It is often used in rheumatoid arthritis. eHealthMe is studying from 636,827 Prednisone users. Check the latest studies of Prednisone.

What is Diffuse large b-cell lymphoma stage iii?

Diffuse large b-cell lymphoma stage iii (cancer of b cells, a type of white blood cell-stage iii) is found to be associated with 13 drugs and 69 conditions by eHealthMe. Check the latest studies of Diffuse large b-cell lymphoma stage iii.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

628,814 people reported to have side effects when taking Prednisone.
Among them, 15 people (0.0%) have Diffuse large b-cell lymphoma stage iii.

Could Prednisone cause Diffuse large b-cell lymphoma stage iii?

Among these 15 people:

How long have people been on Prednisone when they have Diffuse large b-cell lymphoma stage iii? *

What is the gender of people who have Diffuse large b-cell lymphoma stage iii when taking Prednisone? *

female: 53.33 %
male: 46.67 %

What is the age of people who have Diffuse large b-cell lymphoma stage iii when taking Prednisone? *

What are other drugs people take besides Prednisone? *

What are other side effects people have besides Diffuse large b-cell lymphoma stage iii? *

Epstein-Barr Virus Infection: 5 people, 33.33%
Therapeutic Response Decreased (less preventive response): 3 people, 20.00%
Gastrointestinal Toxicity (damage to digestive tract by any substance): 3 people, 20.00%
Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system): 3 people, 20.00%
Drug Ineffective: 2 people, 13.33%
Pneumonia Bacterial (pneumonia associated with bacterial infection): 2 people, 13.33%
Epstein-Barr Virus Associated Lymphoproliferative Disorder (lymphocytes are produced in excessive quantities associated with epstein-barr virus): 2 people, 13.33%
Oral Herpes (viral infection of mouth): 2 people, 13.33%
Epstein-Barr Virus Associated Lymphoma (epstein-barr virus associated tumour): 1 person, 6.67%
Felty's Syndrome (a combination of rheumatoid arthritis, an enlarged spleen, an abnormally low white blood count): 1 person, 6.67%

What are the existing conditions these people have? *

Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 4 people, 26.67%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 3 people, 20.00%
Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 2 people, 13.33%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 6.67%
Peripheral T-Cell Lymphoma Unspecified Stage Iii (peripheral t-cell cancer unspecified stage iii): 1 person, 6.67%
Burkitt Lymphoma (cancer of the lymphatic system): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Prednisone and have Diffuse large b-cell lymphoma stage iii?

- Check whether Diffuse large b-cell lymphoma stage iii is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Prednisone:

Prednisone (636,827 reports)

Diffuse large b-cell lymphoma stage iii treatments and more:

Diffuse large b-cell lymphoma stage iii (714 reports)

How severe was Diffuse large b-cell lymphoma stage iii and when was it recovered:

Diffuse large b-cell lymphoma stage iii in Prednisone

Expand to all the drugs that have ingredients of prednisone:

Diffuse large b-cell lymphoma stage iii and drugs with ingredients of prednisone (15 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Prednisone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Diffuse large b-cell lymphoma stage iii:

Diffuse large b-cell lymphoma stage iii (13 drugs)

Browse all the conditions that are associated with Diffuse large b-cell lymphoma stage iii:

Diffuse large b-cell lymphoma stage iii (69 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on prednisone (the active ingredients of Prednisone) and Prednisone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.